The World On Fire: Five Global Health Stories To Watch In 2020 – Part II 21/01/2020 by Elaine Ruth Fletcher “Creaking health systems” are among the leading risks faced by the global community, according to the World Economic Forum’s Global Risks 2020 Report. People live longer, but health gains have also plateaued in recent decades. Threats from longstanding infections as well as those from emerging diseases pose a double set of challenges. Along with that, […] Continue reading -> The World On Fire: Five Global Health Stories To Watch In 2020 17/01/2020 by Elaine Ruth Fletcher The failed 2019 UN Climate Conference in Madrid ended in mid-December just about when the massive wildfire destruction of Australia’s bushlands was beginning. The wildfires that broke shortly afterward took the form of a Gaia-like revenge. Australia, along with the United States, Japan and Brazil, had been among the countries that had blocked real progress […] Continue reading -> Low Antibiotic Prices Dampen Industry Investment In Vital New Tools To Combat Superbugs – Says AMR Industry Alliance 16/01/2020 by Elaine Ruth Fletcher The low worldwide prices for antibiotics, combined with the need to carefully ration sale of any powerful new drugs that come to market to preserve their efficacy, continue to dampen industry investment in desperately-needed treatments for new drug-resistant superbugs, according to a sweeping new report by the AMR Industry Alliance, released today. While civil society […] Continue reading -> Transparency & Collaboration Key To Defining A “Fair” Price For Essential Medicines 14/01/2020 by Grace Ren More public disclosure and information-sharing about drug prices and their R&D costs, is key to determining a fair price for essential medicines, concludes a series of five articles on fair pricing published Monday in the BMJ. The series, supported in part by the World Health Organization, highlights the increased priority drug price transparency is receiving […] Continue reading -> Mystery Virus in Wuhan Identified As Novel Coronavirus; Researchers Still Searching For Animal Host 13/01/2020 by Grace Ren Chinese authorities have been commended for the speed at which they have identified the genetic make up of a novel coronavirus, 2019-nCoV as the cause of a new pneumonia-like illness in Wuhan, China. The virus has infected 42 people, and is likely transmitted primarily through animals to humans, said a leading infectious disease specialist on […] Continue reading -> Novartis Relinquishes European Patent For Kymriah Cancer Cell Therapy 17/12/2019 by Editorial team Novartis has relinquished a patent granted by the European Patent Office for Kymriah, a promising new gene therapy for certain forms of leukemia, claiming the patent was no longer essential to the development and marketing of the treatment. The decision followed the moves by the Swiss-based NGO, Public Eye and the French-based Doctors of the […] Continue reading -> WHO Recommends Worldwide Adoption Of All Oral-Regimen For MDR/RR-TB 13/12/2019 by Grace Ren The World Health Organization issued new guidelines for the treatment of multi drug-resistant (MDR) tuberculosis on Wednesday, prioritizing for the first time an all-oral treatment regimen. The new treatment recommends replacing the painful injectable drugs that patients had to endure under previous treatment guidelines with a shorter course of oral bedaquiline – one of only […] Continue reading -> Stop TB Partnership Launches New Global Plan, World’s Largest Funding Call For TB Grassroots Organizations, & Pediatric DR-TB Initiative 10/12/2019 by Grace Ren A new plan to dramatically accelerate global efforts to end tuberculosis, one of the world’s deadliest and oldest known infectious diseases, was launched Tuesday by the Stop TB Partnership in Jakarta. The fully-costed plan is based on commitments made at a 2018 United Nations High-Level Meeting on Ending TB (UNHLM) to reduce TB deaths by […] Continue reading -> Criminal Activity On Falsified Medicines “On The Rise” Says Novartis Anti-Counterfeit Head 09/12/2019 by John Zarocostas Criminal activity surrounding the manufacture, distribution and sale of falsified medicines is “on the rise” as a global health problem in many developing countries and in rich nations – especially online – but efforts to stem the growing health threat will require robust collective action by all stakeholders, a leading Novartis official warned Friday in […] Continue reading -> Creative Approaches To Improving Medicines Access – Lessons From The Hepatitis C Experience 06/12/2019 by Elaine Ruth Fletcher The issues around access to medicines at affordable prices has galvanized civil society, the pharmaceutical industry, the research community, and politicians this year in oft-contentious debate that shows no sign of abating. A day-long session hosted by the Global Health Centre of Geneva’s Graduate Institute, and cosponsored by the Swiss Institute of Intellectual Property and […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
The World On Fire: Five Global Health Stories To Watch In 2020 17/01/2020 by Elaine Ruth Fletcher The failed 2019 UN Climate Conference in Madrid ended in mid-December just about when the massive wildfire destruction of Australia’s bushlands was beginning. The wildfires that broke shortly afterward took the form of a Gaia-like revenge. Australia, along with the United States, Japan and Brazil, had been among the countries that had blocked real progress […] Continue reading -> Low Antibiotic Prices Dampen Industry Investment In Vital New Tools To Combat Superbugs – Says AMR Industry Alliance 16/01/2020 by Elaine Ruth Fletcher The low worldwide prices for antibiotics, combined with the need to carefully ration sale of any powerful new drugs that come to market to preserve their efficacy, continue to dampen industry investment in desperately-needed treatments for new drug-resistant superbugs, according to a sweeping new report by the AMR Industry Alliance, released today. While civil society […] Continue reading -> Transparency & Collaboration Key To Defining A “Fair” Price For Essential Medicines 14/01/2020 by Grace Ren More public disclosure and information-sharing about drug prices and their R&D costs, is key to determining a fair price for essential medicines, concludes a series of five articles on fair pricing published Monday in the BMJ. The series, supported in part by the World Health Organization, highlights the increased priority drug price transparency is receiving […] Continue reading -> Mystery Virus in Wuhan Identified As Novel Coronavirus; Researchers Still Searching For Animal Host 13/01/2020 by Grace Ren Chinese authorities have been commended for the speed at which they have identified the genetic make up of a novel coronavirus, 2019-nCoV as the cause of a new pneumonia-like illness in Wuhan, China. The virus has infected 42 people, and is likely transmitted primarily through animals to humans, said a leading infectious disease specialist on […] Continue reading -> Novartis Relinquishes European Patent For Kymriah Cancer Cell Therapy 17/12/2019 by Editorial team Novartis has relinquished a patent granted by the European Patent Office for Kymriah, a promising new gene therapy for certain forms of leukemia, claiming the patent was no longer essential to the development and marketing of the treatment. The decision followed the moves by the Swiss-based NGO, Public Eye and the French-based Doctors of the […] Continue reading -> WHO Recommends Worldwide Adoption Of All Oral-Regimen For MDR/RR-TB 13/12/2019 by Grace Ren The World Health Organization issued new guidelines for the treatment of multi drug-resistant (MDR) tuberculosis on Wednesday, prioritizing for the first time an all-oral treatment regimen. The new treatment recommends replacing the painful injectable drugs that patients had to endure under previous treatment guidelines with a shorter course of oral bedaquiline – one of only […] Continue reading -> Stop TB Partnership Launches New Global Plan, World’s Largest Funding Call For TB Grassroots Organizations, & Pediatric DR-TB Initiative 10/12/2019 by Grace Ren A new plan to dramatically accelerate global efforts to end tuberculosis, one of the world’s deadliest and oldest known infectious diseases, was launched Tuesday by the Stop TB Partnership in Jakarta. The fully-costed plan is based on commitments made at a 2018 United Nations High-Level Meeting on Ending TB (UNHLM) to reduce TB deaths by […] Continue reading -> Criminal Activity On Falsified Medicines “On The Rise” Says Novartis Anti-Counterfeit Head 09/12/2019 by John Zarocostas Criminal activity surrounding the manufacture, distribution and sale of falsified medicines is “on the rise” as a global health problem in many developing countries and in rich nations – especially online – but efforts to stem the growing health threat will require robust collective action by all stakeholders, a leading Novartis official warned Friday in […] Continue reading -> Creative Approaches To Improving Medicines Access – Lessons From The Hepatitis C Experience 06/12/2019 by Elaine Ruth Fletcher The issues around access to medicines at affordable prices has galvanized civil society, the pharmaceutical industry, the research community, and politicians this year in oft-contentious debate that shows no sign of abating. A day-long session hosted by the Global Health Centre of Geneva’s Graduate Institute, and cosponsored by the Swiss Institute of Intellectual Property and […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Low Antibiotic Prices Dampen Industry Investment In Vital New Tools To Combat Superbugs – Says AMR Industry Alliance 16/01/2020 by Elaine Ruth Fletcher The low worldwide prices for antibiotics, combined with the need to carefully ration sale of any powerful new drugs that come to market to preserve their efficacy, continue to dampen industry investment in desperately-needed treatments for new drug-resistant superbugs, according to a sweeping new report by the AMR Industry Alliance, released today. While civil society […] Continue reading -> Transparency & Collaboration Key To Defining A “Fair” Price For Essential Medicines 14/01/2020 by Grace Ren More public disclosure and information-sharing about drug prices and their R&D costs, is key to determining a fair price for essential medicines, concludes a series of five articles on fair pricing published Monday in the BMJ. The series, supported in part by the World Health Organization, highlights the increased priority drug price transparency is receiving […] Continue reading -> Mystery Virus in Wuhan Identified As Novel Coronavirus; Researchers Still Searching For Animal Host 13/01/2020 by Grace Ren Chinese authorities have been commended for the speed at which they have identified the genetic make up of a novel coronavirus, 2019-nCoV as the cause of a new pneumonia-like illness in Wuhan, China. The virus has infected 42 people, and is likely transmitted primarily through animals to humans, said a leading infectious disease specialist on […] Continue reading -> Novartis Relinquishes European Patent For Kymriah Cancer Cell Therapy 17/12/2019 by Editorial team Novartis has relinquished a patent granted by the European Patent Office for Kymriah, a promising new gene therapy for certain forms of leukemia, claiming the patent was no longer essential to the development and marketing of the treatment. The decision followed the moves by the Swiss-based NGO, Public Eye and the French-based Doctors of the […] Continue reading -> WHO Recommends Worldwide Adoption Of All Oral-Regimen For MDR/RR-TB 13/12/2019 by Grace Ren The World Health Organization issued new guidelines for the treatment of multi drug-resistant (MDR) tuberculosis on Wednesday, prioritizing for the first time an all-oral treatment regimen. The new treatment recommends replacing the painful injectable drugs that patients had to endure under previous treatment guidelines with a shorter course of oral bedaquiline – one of only […] Continue reading -> Stop TB Partnership Launches New Global Plan, World’s Largest Funding Call For TB Grassroots Organizations, & Pediatric DR-TB Initiative 10/12/2019 by Grace Ren A new plan to dramatically accelerate global efforts to end tuberculosis, one of the world’s deadliest and oldest known infectious diseases, was launched Tuesday by the Stop TB Partnership in Jakarta. The fully-costed plan is based on commitments made at a 2018 United Nations High-Level Meeting on Ending TB (UNHLM) to reduce TB deaths by […] Continue reading -> Criminal Activity On Falsified Medicines “On The Rise” Says Novartis Anti-Counterfeit Head 09/12/2019 by John Zarocostas Criminal activity surrounding the manufacture, distribution and sale of falsified medicines is “on the rise” as a global health problem in many developing countries and in rich nations – especially online – but efforts to stem the growing health threat will require robust collective action by all stakeholders, a leading Novartis official warned Friday in […] Continue reading -> Creative Approaches To Improving Medicines Access – Lessons From The Hepatitis C Experience 06/12/2019 by Elaine Ruth Fletcher The issues around access to medicines at affordable prices has galvanized civil society, the pharmaceutical industry, the research community, and politicians this year in oft-contentious debate that shows no sign of abating. A day-long session hosted by the Global Health Centre of Geneva’s Graduate Institute, and cosponsored by the Swiss Institute of Intellectual Property and […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Transparency & Collaboration Key To Defining A “Fair” Price For Essential Medicines 14/01/2020 by Grace Ren More public disclosure and information-sharing about drug prices and their R&D costs, is key to determining a fair price for essential medicines, concludes a series of five articles on fair pricing published Monday in the BMJ. The series, supported in part by the World Health Organization, highlights the increased priority drug price transparency is receiving […] Continue reading -> Mystery Virus in Wuhan Identified As Novel Coronavirus; Researchers Still Searching For Animal Host 13/01/2020 by Grace Ren Chinese authorities have been commended for the speed at which they have identified the genetic make up of a novel coronavirus, 2019-nCoV as the cause of a new pneumonia-like illness in Wuhan, China. The virus has infected 42 people, and is likely transmitted primarily through animals to humans, said a leading infectious disease specialist on […] Continue reading -> Novartis Relinquishes European Patent For Kymriah Cancer Cell Therapy 17/12/2019 by Editorial team Novartis has relinquished a patent granted by the European Patent Office for Kymriah, a promising new gene therapy for certain forms of leukemia, claiming the patent was no longer essential to the development and marketing of the treatment. The decision followed the moves by the Swiss-based NGO, Public Eye and the French-based Doctors of the […] Continue reading -> WHO Recommends Worldwide Adoption Of All Oral-Regimen For MDR/RR-TB 13/12/2019 by Grace Ren The World Health Organization issued new guidelines for the treatment of multi drug-resistant (MDR) tuberculosis on Wednesday, prioritizing for the first time an all-oral treatment regimen. The new treatment recommends replacing the painful injectable drugs that patients had to endure under previous treatment guidelines with a shorter course of oral bedaquiline – one of only […] Continue reading -> Stop TB Partnership Launches New Global Plan, World’s Largest Funding Call For TB Grassroots Organizations, & Pediatric DR-TB Initiative 10/12/2019 by Grace Ren A new plan to dramatically accelerate global efforts to end tuberculosis, one of the world’s deadliest and oldest known infectious diseases, was launched Tuesday by the Stop TB Partnership in Jakarta. The fully-costed plan is based on commitments made at a 2018 United Nations High-Level Meeting on Ending TB (UNHLM) to reduce TB deaths by […] Continue reading -> Criminal Activity On Falsified Medicines “On The Rise” Says Novartis Anti-Counterfeit Head 09/12/2019 by John Zarocostas Criminal activity surrounding the manufacture, distribution and sale of falsified medicines is “on the rise” as a global health problem in many developing countries and in rich nations – especially online – but efforts to stem the growing health threat will require robust collective action by all stakeholders, a leading Novartis official warned Friday in […] Continue reading -> Creative Approaches To Improving Medicines Access – Lessons From The Hepatitis C Experience 06/12/2019 by Elaine Ruth Fletcher The issues around access to medicines at affordable prices has galvanized civil society, the pharmaceutical industry, the research community, and politicians this year in oft-contentious debate that shows no sign of abating. A day-long session hosted by the Global Health Centre of Geneva’s Graduate Institute, and cosponsored by the Swiss Institute of Intellectual Property and […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Mystery Virus in Wuhan Identified As Novel Coronavirus; Researchers Still Searching For Animal Host 13/01/2020 by Grace Ren Chinese authorities have been commended for the speed at which they have identified the genetic make up of a novel coronavirus, 2019-nCoV as the cause of a new pneumonia-like illness in Wuhan, China. The virus has infected 42 people, and is likely transmitted primarily through animals to humans, said a leading infectious disease specialist on […] Continue reading -> Novartis Relinquishes European Patent For Kymriah Cancer Cell Therapy 17/12/2019 by Editorial team Novartis has relinquished a patent granted by the European Patent Office for Kymriah, a promising new gene therapy for certain forms of leukemia, claiming the patent was no longer essential to the development and marketing of the treatment. The decision followed the moves by the Swiss-based NGO, Public Eye and the French-based Doctors of the […] Continue reading -> WHO Recommends Worldwide Adoption Of All Oral-Regimen For MDR/RR-TB 13/12/2019 by Grace Ren The World Health Organization issued new guidelines for the treatment of multi drug-resistant (MDR) tuberculosis on Wednesday, prioritizing for the first time an all-oral treatment regimen. The new treatment recommends replacing the painful injectable drugs that patients had to endure under previous treatment guidelines with a shorter course of oral bedaquiline – one of only […] Continue reading -> Stop TB Partnership Launches New Global Plan, World’s Largest Funding Call For TB Grassroots Organizations, & Pediatric DR-TB Initiative 10/12/2019 by Grace Ren A new plan to dramatically accelerate global efforts to end tuberculosis, one of the world’s deadliest and oldest known infectious diseases, was launched Tuesday by the Stop TB Partnership in Jakarta. The fully-costed plan is based on commitments made at a 2018 United Nations High-Level Meeting on Ending TB (UNHLM) to reduce TB deaths by […] Continue reading -> Criminal Activity On Falsified Medicines “On The Rise” Says Novartis Anti-Counterfeit Head 09/12/2019 by John Zarocostas Criminal activity surrounding the manufacture, distribution and sale of falsified medicines is “on the rise” as a global health problem in many developing countries and in rich nations – especially online – but efforts to stem the growing health threat will require robust collective action by all stakeholders, a leading Novartis official warned Friday in […] Continue reading -> Creative Approaches To Improving Medicines Access – Lessons From The Hepatitis C Experience 06/12/2019 by Elaine Ruth Fletcher The issues around access to medicines at affordable prices has galvanized civil society, the pharmaceutical industry, the research community, and politicians this year in oft-contentious debate that shows no sign of abating. A day-long session hosted by the Global Health Centre of Geneva’s Graduate Institute, and cosponsored by the Swiss Institute of Intellectual Property and […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Novartis Relinquishes European Patent For Kymriah Cancer Cell Therapy 17/12/2019 by Editorial team Novartis has relinquished a patent granted by the European Patent Office for Kymriah, a promising new gene therapy for certain forms of leukemia, claiming the patent was no longer essential to the development and marketing of the treatment. The decision followed the moves by the Swiss-based NGO, Public Eye and the French-based Doctors of the […] Continue reading -> WHO Recommends Worldwide Adoption Of All Oral-Regimen For MDR/RR-TB 13/12/2019 by Grace Ren The World Health Organization issued new guidelines for the treatment of multi drug-resistant (MDR) tuberculosis on Wednesday, prioritizing for the first time an all-oral treatment regimen. The new treatment recommends replacing the painful injectable drugs that patients had to endure under previous treatment guidelines with a shorter course of oral bedaquiline – one of only […] Continue reading -> Stop TB Partnership Launches New Global Plan, World’s Largest Funding Call For TB Grassroots Organizations, & Pediatric DR-TB Initiative 10/12/2019 by Grace Ren A new plan to dramatically accelerate global efforts to end tuberculosis, one of the world’s deadliest and oldest known infectious diseases, was launched Tuesday by the Stop TB Partnership in Jakarta. The fully-costed plan is based on commitments made at a 2018 United Nations High-Level Meeting on Ending TB (UNHLM) to reduce TB deaths by […] Continue reading -> Criminal Activity On Falsified Medicines “On The Rise” Says Novartis Anti-Counterfeit Head 09/12/2019 by John Zarocostas Criminal activity surrounding the manufacture, distribution and sale of falsified medicines is “on the rise” as a global health problem in many developing countries and in rich nations – especially online – but efforts to stem the growing health threat will require robust collective action by all stakeholders, a leading Novartis official warned Friday in […] Continue reading -> Creative Approaches To Improving Medicines Access – Lessons From The Hepatitis C Experience 06/12/2019 by Elaine Ruth Fletcher The issues around access to medicines at affordable prices has galvanized civil society, the pharmaceutical industry, the research community, and politicians this year in oft-contentious debate that shows no sign of abating. A day-long session hosted by the Global Health Centre of Geneva’s Graduate Institute, and cosponsored by the Swiss Institute of Intellectual Property and […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
WHO Recommends Worldwide Adoption Of All Oral-Regimen For MDR/RR-TB 13/12/2019 by Grace Ren The World Health Organization issued new guidelines for the treatment of multi drug-resistant (MDR) tuberculosis on Wednesday, prioritizing for the first time an all-oral treatment regimen. The new treatment recommends replacing the painful injectable drugs that patients had to endure under previous treatment guidelines with a shorter course of oral bedaquiline – one of only […] Continue reading -> Stop TB Partnership Launches New Global Plan, World’s Largest Funding Call For TB Grassroots Organizations, & Pediatric DR-TB Initiative 10/12/2019 by Grace Ren A new plan to dramatically accelerate global efforts to end tuberculosis, one of the world’s deadliest and oldest known infectious diseases, was launched Tuesday by the Stop TB Partnership in Jakarta. The fully-costed plan is based on commitments made at a 2018 United Nations High-Level Meeting on Ending TB (UNHLM) to reduce TB deaths by […] Continue reading -> Criminal Activity On Falsified Medicines “On The Rise” Says Novartis Anti-Counterfeit Head 09/12/2019 by John Zarocostas Criminal activity surrounding the manufacture, distribution and sale of falsified medicines is “on the rise” as a global health problem in many developing countries and in rich nations – especially online – but efforts to stem the growing health threat will require robust collective action by all stakeholders, a leading Novartis official warned Friday in […] Continue reading -> Creative Approaches To Improving Medicines Access – Lessons From The Hepatitis C Experience 06/12/2019 by Elaine Ruth Fletcher The issues around access to medicines at affordable prices has galvanized civil society, the pharmaceutical industry, the research community, and politicians this year in oft-contentious debate that shows no sign of abating. A day-long session hosted by the Global Health Centre of Geneva’s Graduate Institute, and cosponsored by the Swiss Institute of Intellectual Property and […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Stop TB Partnership Launches New Global Plan, World’s Largest Funding Call For TB Grassroots Organizations, & Pediatric DR-TB Initiative 10/12/2019 by Grace Ren A new plan to dramatically accelerate global efforts to end tuberculosis, one of the world’s deadliest and oldest known infectious diseases, was launched Tuesday by the Stop TB Partnership in Jakarta. The fully-costed plan is based on commitments made at a 2018 United Nations High-Level Meeting on Ending TB (UNHLM) to reduce TB deaths by […] Continue reading -> Criminal Activity On Falsified Medicines “On The Rise” Says Novartis Anti-Counterfeit Head 09/12/2019 by John Zarocostas Criminal activity surrounding the manufacture, distribution and sale of falsified medicines is “on the rise” as a global health problem in many developing countries and in rich nations – especially online – but efforts to stem the growing health threat will require robust collective action by all stakeholders, a leading Novartis official warned Friday in […] Continue reading -> Creative Approaches To Improving Medicines Access – Lessons From The Hepatitis C Experience 06/12/2019 by Elaine Ruth Fletcher The issues around access to medicines at affordable prices has galvanized civil society, the pharmaceutical industry, the research community, and politicians this year in oft-contentious debate that shows no sign of abating. A day-long session hosted by the Global Health Centre of Geneva’s Graduate Institute, and cosponsored by the Swiss Institute of Intellectual Property and […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Criminal Activity On Falsified Medicines “On The Rise” Says Novartis Anti-Counterfeit Head 09/12/2019 by John Zarocostas Criminal activity surrounding the manufacture, distribution and sale of falsified medicines is “on the rise” as a global health problem in many developing countries and in rich nations – especially online – but efforts to stem the growing health threat will require robust collective action by all stakeholders, a leading Novartis official warned Friday in […] Continue reading -> Creative Approaches To Improving Medicines Access – Lessons From The Hepatitis C Experience 06/12/2019 by Elaine Ruth Fletcher The issues around access to medicines at affordable prices has galvanized civil society, the pharmaceutical industry, the research community, and politicians this year in oft-contentious debate that shows no sign of abating. A day-long session hosted by the Global Health Centre of Geneva’s Graduate Institute, and cosponsored by the Swiss Institute of Intellectual Property and […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Creative Approaches To Improving Medicines Access – Lessons From The Hepatitis C Experience 06/12/2019 by Elaine Ruth Fletcher The issues around access to medicines at affordable prices has galvanized civil society, the pharmaceutical industry, the research community, and politicians this year in oft-contentious debate that shows no sign of abating. A day-long session hosted by the Global Health Centre of Geneva’s Graduate Institute, and cosponsored by the Swiss Institute of Intellectual Property and […] Continue reading -> Posts navigation Older posts